CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,658 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01119716
NCT01119716N/ACompleted

International Registry on Cardioversion of Atrial Fibrillation

Merck Sharp & Dohme LLC·observational·Posted May 7, 2010·Updated Jun 12, 2024

In Brief

An observational study for Atrial Fibrillation. Completed, enrolled 4,658 participants.

Detailed Summary

This study will create a prospective registry of consecutive patients with Atrial Fibrillation (Afib) considered for cardioversion treatment to document up-to-date practice of in-hospital treatment, with a focus on the characterization of type of Afib, as well as on treatments applied (drugs, devices, interventions and their combinations), and associated complications within 60 days after enrollment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 7, 2010
Enrollment StartMay 25, 2010
Primary CompletionFeb 15, 2013
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 16.2 years ago